Author: digi

Stability SOP: Step-by-Step FDA/ICH Compliance-Ready Procedures & Checklist

Stability SOP: Interpreting Regulatory Expectations for Compliance-Ready Procedures Updated September 2025 — A detailed interpretation of regulatory requirements for developing robust SOPs in pharmaceutical stability studies, including FDA, EMA, WHO, and CDSCO perspectives. Why Stability SOPs Are Critical for Compliance Standard Operating Procedures (SOPs) are the backbone of any pharmaceutical quality system, and in stability…

Stability Studies SOP

Mapping ICH Stability Across Climatic Zones: Step-by-Step Global Compliance Guide

ICH Stability Testing Across Climatic Zones: A Global Compliance Roadmap Updated September 2025 — A detailed guide to navigating ICH stability requirements across global climatic zones, including WHO, FDA, EMA, CDSCO, and ANVISA perspectives. Why Climatic Zones Matter in Stability Testing Pharmaceutical stability is not only about time — it is also about geography. A…

ICH Stability Guidelines (Q1A–Q1E, Q8, Q9, etc.)

FDA Stability Requirements: Step-by-Step Compliance-Ready Checklist for NDA & ANDA Success

Comprehensive Guide to FDA Stability Requirements for Pharmaceutical Approvals Updated September 2025 — A full-length, compliance-focused guide to meeting FDA stability expectations in NDA, ANDA, and BLA submissions. Why FDA Stability Requirements Matter The U.S. Food and Drug Administration (FDA) is widely recognized as the strictest regulatory body when it comes to pharmaceutical stability testing….

Regional Guidelines: FDA, EMA, ASEAN, TGA

Retest vs Expiry Dates in Pharma: Step-by-Step Regulatory Checklist for CTD/CMC Compliance

Navigating Retest Periods and Expiry Dates in Regulatory Submissions Updated September 2025 — A compliance-ready guide for CMC teams to correctly justify and document retest periods (drug substance) and expiry dates (drug product) in eCTD dossiers. When regulators review your dossier, they expect absolute clarity on one deceptively simple distinction: retest period vs. expiry date….

Re-Test Period vs. Shelf Life in Pharmaceuticals

Shelf Life & Expiry Dating for CTD/CMC Submissions: FDA-Approved, Step-by-Step Dossier Checklist (ICH Q1A–Q1E, Q5C)

Submission-Ready Shelf Life & Expiry Dating for CTD/CMC Teams Updated September 2025 — A compliance-first guide to building and defending shelf life and expiry dating in eCTD for small molecules and biologics. When reviewers open your eCTD, they look for one thing straight away: does the dossier justify the proposed shelf life with defensible, statistically…

Shelf Life and Expiry Dating, Shelf Life vs. Expiration Date: Key Differences

Shelf Life and Expiry Dating in Pharmaceuticals: FDA-Approved Step-by-Step Guide with Case Studies

Step-by-Step Guide to Determining Shelf Life and Expiry Dating in Pharmaceuticals Updated September 2025 — A comprehensive, compliance-ready resource for understanding shelf life and expiry determination across oral solids, injectables, biologics, and vaccines. Few elements in pharmaceuticals carry as much weight with patients and regulators as the expiry date printed on a medicine pack. To…

Re-Test Period vs. Shelf Life in Pharmaceutical Stability

Freeze-Thaw Stability Testing Guide: FDA-Compliant Step-by-Step Checklist for Pharma & Biologics

Step-by-Step Guide to Freeze-Thaw Stability Testing for Pharmaceuticals and Biologics Updated September 2025 to reflect the latest FDA, EMA, WHO, and ICH expectations for freeze-thaw stability testing across small molecules, injectables, and biologics. Pharmaceutical products rarely experience perfect storage conditions in real life. From shipping vaccines across continents to transporting injectables through regional distribution hubs,…

Forced Degradation and Stress Testing Techniques, Freeze-Thaw and Thermal Cycling Studies

ICH Accelerated Stability Guidelines: Step-by-Step Compliance-Ready Checklist for FDA-Approved Pharma

Step-by-Step Guide to ICH Accelerated Stability Testing for Regulatory Compliance Originally published in August 2025, updated September 2025 to reflect the latest ICH Q1A(R2) accelerated stability requirements recognized by FDA, EMA, and WHO. Before the establishment of harmonized ICH guidelines, pharmaceutical stability testing was a fragmented and confusing process. Each major regulator — the FDA…

Accelerated Stability Testing of APIs, ICH Stability Guidelines (Q1A–Q1E, Q8, Q9, etc.)

SOP for Conducting Stability Studies for Drugs with Complex API in Compliance with Regulatory Guidelines

SOP for Conducting Stability Studies for Drugs with Complex API in Compliance with Regulatory Guidelines Procedure for Stability Testing of Drugs with Complex APIs 1) Purpose The purpose of this SOP is to define a procedure for conducting stability studies for drugs with complex active pharmaceutical ingredients (APIs) in compliance with relevant regulatory guidelines. This…

Stability Studies SOP

Align Site Master File and Stability Practices During Audits

Understanding the Tip: Why alignment between documentation and actual practice is critical: The Site Master File (SMF) is a regulatory-facing document that provides a high-level overview of your facility’s GMP systems, including stability studies. It often serves as the first reference point for auditors. Any misalignment between what’s described in the SMF and what is…

Stability Study Tips